1309P A genomic scar based signature (HRDsig) and biallelic BRCA alterations identify a homologous recombination deficiency (HRD) phenotype of non-small cell lung cancer (NSCLC) potentially actionable to the PARP inhibitor rucaparib: Post-hoc analysis of lung-MAP substudy S1900A

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 35; pp. S832 - S833
Main Authors Riess, J.W., Miao, J., Wheatley-Price, P., Reckamp, K.L., Kozono, D., Redman, M.W., Edelman, M.J., Faller, B., Villaruz, L., Corum, L., Gowda, A., Srkalovic, G., Osarogiagbon, R., Baumgart, M., Gandara, D.R., Sokol, E.S., Borghaei, H., Gray, J.E., Herbst, R.S., Kelly, K.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2024
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2024.08.1366